| Current Price | $33.17 | Mkt Cap | $2.2B |
|---|---|---|---|
| Open | $33.03 | P/E Ratio | 0.00 |
| Prev. Close | $33.15 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $32.79 - $33.58 | Volume | 935,363 |
| 52-Wk Range | $24.24 - $68.39 | Avg. Daily Vol. | 1,128,415 |
| Current Price | $33.17 | Mkt Cap | $2.2B |
|---|---|---|---|
| Open | $33.03 | P/E Ratio | 0.00 |
| Prev. Close | $33.15 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $32.79 - $33.58 | Volume | 935,363 |
| 52-Wk Range | $24.24 - $68.39 | Avg. Daily Vol. | 1,128,415 |
The best Bull and Bear pitches based on recency and number of recommendations.
Extended delays with getting regulatory approval in the U.S., IP infringement lawsuits against them, and competing in several very crowded disease therapeutics markets where it has no clear product advantage over the competition.
Read the most recent pitches from players about BLUE.
Recs
TMFjimhalley
(60.29)
Submitted: 6/10/2021 5:34:19 PM :
Start Price:
$34.25
NASDAQ:BLUE Score:
-2.34
Biotech with a burgeoning portfolio of gene-editing therapies should shoot up once any of its therapies is approved and several are in Phase 3 trials.
Recs
Car12703
(63.20)
Submitted: 4/25/2021 9:19:00 AM :
Start Price:
$28.50
NASDAQ:BLUE Score:
+15.60
Positive conviction rating.
Recs
italianbarber
(89.46)
Submitted: 6/4/2020 2:30:46 PM :
Start Price:
$67.82
NASDAQ:BLUE Score:
-86.40
Lots of things in the pipeline and the stock has gotten killed.
Find the members with the highest scoring picks in BLUE.
DoubleBagel (32.58) Score: +669.10
The Score Leader is the player with the highest score across all their picks in BLUE.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
|
CommodityBuyer | < 20 | 7/10/2015 |
|
5Y | $160.69 | -79.36% | +102.87% | +182.23 | 0 Comment |
| MotleyFolJohn | < 20 | 2/2/2015 |
|
1Y | $93.98 | -64.71% | +110.71% | +175.41 | 1 Comment | |
| GreenAB | 27.94 | 3/5/2015 |
|
NS | $106.20 | -68.77% | +99.64% | +168.41 | 0 Comment | |
| pro64grammer | 28.42 | 12/9/2014 |
|
5Y | $79.58 | -58.32% | +105.55% | +163.87 | 0 Comment | |
| coptermech66 | < 20 | 10/29/2015 |
|
3Y | $79.54 | -58.30% | +101.49% | +159.79 | 1 Comment | |
| biotechf | 73.31 | 1/22/2016 |
|
3M | $44.44 | -25.36% | +122.24% | +147.60 | 0 Comment | |
| baselineace | 21.68 |
|
|
5Y | $151.50 | -78.11% | +63.51% | +141.62 | 0 Comment | |
| 3rdChanceTom | 87.84 | 3/11/2016 |
|
5Y | $45.77 | -27.53% | +109.05% | +136.58 | 0 Comment | |
| secohen11 | 29.98 | 7/2/2013 |
|
1Y | $26.20 | +26.60% | +161.13% | +134.53 | 0 Comment | |
| saab93boi | < 20 | 6/19/2013 |
|
5Y | $25.68 | +29.19% | +155.91% | +126.72 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
